Earnings call transcripts

Management framed fiscal 2026 as a share-gain year despite muted housing activity, with investments continuing and macro support deliberately excluded from plans.

Management framed 2026 as a transition year focused on channel productivity, new product commercialization, margin expansion, and delayed long-range-plan benefits.

Management framed the quarter as a durable recovery from the cyber disruption, with improving execution, market share gains, and a leadership transition underway.

Management framed 2026 as an execution year, with automation, cross-selling and noravant extending growth while tariffs test margin expansion.

Management framed 2026 as a share-gain year despite a difficult traffic backdrop, emphasizing marketing, menu changes and disciplined expansion over near-term pricing.

Management framed 2026 as an execution year, with durable regulated growth, cautious data-center optionality, and normalization of market-driven earnings upside.

Management framed the miss as a potentially biased open-label comparison, while defending CagriSema’s prospects through redesigned and higher-dose trials.

Management framed the recapitalization as removing balance-sheet constraints and enabling faster project development, while emphasizing execution milestones and unresolved technical-study details.

Management framed 2026 around cash preservation and selective investment, while arguing that input-cost pressure and early signs of nylon capacity rationalization create both risks and openings.

Management framed 2026 as the payoff phase of a transformation, with Edge AI demand and platform expansion offsetting a difficult 2025.

Management framed 2026 as a transition year, with strikes providing a near-term surge while core businesses recover at different speeds.

Management framed 2026 around recovering disrupted production, monetizing Hawesville, advancing Oklahoma, and deploying substantial cash flow.